Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2025 of 2228 entries
View as:

Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00144222 Org: User:
Start: 01/31/05 End: 08/31/05 Due: 08/31/06

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02278302 Org: User:
Start: 08/31/99 End: - Due: -

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00860262 Org: User:
Start: 03/31/09 End: - Due: -

This Study in Healthy Men and Women Tests How the Body Takes up BI 409306

Phase: N/A Priority: Normal
NCT ID: NCT03505151 Org: User:
Start: 04/27/18 End: 05/19/18 Due: 05/19/19

Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02177500 Org: User:
Start: 01/31/00 End: - Due: -

BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01214616 Org: User:
Start: 10/01/10 End: 05/01/13 Due: 05/01/14

Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

Phase: N/A Priority: Normal
NCT ID: NCT00146341 Org: User:
Start: 04/30/05 End: 09/30/06 Due: 09/30/07

TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT00886288 Org: User:
Start: 09/30/06 End: - Due: -

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme

Phase: N/A Priority: Normal
NCT ID: NCT00311402 Org: User:
Start: 04/30/06 End: - Due: -

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Phase: N/A Priority: Normal
NCT ID: NCT02081807 Org: User:
Start: 03/07/14 End: 11/01/17 Due: 11/01/18

Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02226926 Org: User:
Start: 07/31/00 End: - Due: -

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

Phase: N/A Priority: Normal
NCT ID: NCT00800683 Org: User:
Start: 12/31/08 End: - Due: -

Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)

Phase: N/A Priority: Normal
NCT ID: NCT01721876 Org: User:
Start: 01/29/13 End: 05/28/21 Due: 05/28/22

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00824382 Org: User:
Start: 01/31/09 End: - Due: -

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I

Phase: N/A Priority: Normal
NCT ID: NCT00793624 Org: User:
Start: 02/28/09 End: - Due: -

Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks

Phase: N/A Priority: Normal
NCT ID: NCT00743015 Org: User:
Start: 09/30/08 End: - Due: -

A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)

Phase: N/A Priority: Normal
NCT ID: NCT02182011 Org: User:
Start: 05/31/00 End: - Due: -

A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

Phase: N/A Priority: Normal
NCT ID: NCT00240448 Org: User:
Start: 09/30/03 End: - Due: -

Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02211157 Org: User:
Start: 03/31/00 End: - Due: -

High Dose Trial in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00128440 Org: User:
Start: 08/31/05 End: - Due: -

Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations

Phase: N/A Priority: Normal
NCT ID: NCT02044380 Org: User:
Start: 03/31/14 End: 02/29/16 Due: 02/28/17

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06806592 Org: User:
Start: 08/21/25 End: 07/30/27 Due: 07/30/28

Fingerprinting of Impulsivity

Phase: N/A Priority: Normal
NCT ID: NCT02722174 Org: User:
Start: 07/22/16 End: 09/06/18 Due: 09/06/19

Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid

Phase: N/A Priority: Normal
NCT ID: NCT00915772 Org: User:
Start: 06/30/09 End: - Due: -

Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02242812 Org: User:
Start: 09/30/03 End: - Due: -